- Recommendation basesd on reliable evidence --- this is the basic stance of Fujicco
- Two findings related to Equol
- Bone Health
- First in the world - confirmation of Bone Loss Preventing Effect by pure reagent
- Confirmation of the condition whereby: 'A person with high bone density has a high amount of urinary Isoflavones'
- By intake of Isoflavones, the urinary excretion of Bone Absorption Marker decreases
Restriction of Ca elution from bone was proven - Drinking Fujicco Tea containing Isoflavones proved the effect
- When exercise is added to intake of Isoflavones, Bone Density increases
- Walking combined with Fujiflavone intake prevents Bone Loss and reduces Body Fat
- More than 90mg Isoflavone intake increases Spine Bone Density of menopausal women
- Isoflavones promote Bone Formation
- Estrogen's Bone Mass Maintenance Mechanism made clear:
Important point of action is 'regulation of Osteoclasts life span'
- Menopausal Symptoms
- Occurrence of Hot Flashes among a group ingesting some amount of Isoflavones is less than half of that among a group taking a smaller amount
- Intake of Isoflavones prevents Atrophy of Mucosa and provides moisture
- Effect for Beautiful Skin confirmed:
Moisture maintenance・collagen creation・suppressing action against melanin
- Obesity
- Cardiovascular Diseases
- High Isoflavone Intake women group showed reduction of Cerebral and Myocardial Infarction Risk
- Isoflavone Intake lowers Blood Pressure
- Isoflavones reduce Serum Cholesterol
- Intake of 100mg Isoflavones lowers Serum Total Cholesterol and LDL Cholesterol
- A hypothesis of Isoflavones' Blood Pressure Reducing Mechanism was presented
- Cancers etc.
- Breast Cancer Mortality Rate is low in Soybean eating regions while in low Isoflavone Intake areas the mortality rate is high
- Isoflavones lower Breast Cancer Risk
- High Blood Isoflavone (Genistein) Level group shows lower Breast Cancer Incidence Rate
- Isoflavones prevent progress of Prostate Cancer
- Risk of Localized Prostate Cancer is lowered in higher Isoflavone Intake group
- High Soy Products intake group shows Mortality Rate Risk of Stomach Cancer reduced by half
- Isoflavones suppress Stress Induced Stomach Ulcer
Cancers etc.
High Soy Products intake group shows Mortality Rate Risk of Stomach Cancer reduced by half
The 'Takayama Cohort' study conducted by Gifu University School of Medicine is a prospective cohort study on 30,000 citizens of Takayama city, Gifu prefecture.
The research was started in 1992, and 7 years later in 1999, a follow-up was conducted to find the dietary habits of the subjects who died from stomach cancer, and analyzed the correlations (as a matter of course, other factors providing effects or causing interference on stomach cancer were calculated and exempted at the examinations.)
By the volume of soy products intake, they were divided into 3 groups （Low, Middle and High） and the relation with death from stomach cancer was examined. If the number of deaths from stomach cancer in the low soy products intake group is taken as 1, in the high intake group the relative hazard ratio is approximately just less than 0.5 (men 0.50, women 0.49), and it is reported that the hazard ratio of death from stomach cancer is reduced by almost half. Similar correlation was observed even when the comparison was made by converting the intake volume into isoflavone intake volume.
Br J Cancer, 87 (1), 31-36:2002
